Opening Plenary Session 1: Emerging Therapeutics for OA
Date/Time: Friday, March 17, 2023 - 1:45 PM to 3:30 PM
Log in to Add to My Schedule
Description:
Current Landscape of Regenerative Medicine Approaches in Osteoarthritis
Frank Barry
When Neuro-Immune Communication Meets Arthritis
Kevin J. Tracey
Sponsored by Fidia
Abstract(s):
O-1
INCREASED JOINT LOADING 1 MONTH AFTER PLATELETRICH
PLASMA TREATMENT OF KNEE OA IS ASSOCIATED
WITH IMPROVED CLINICAL OUTCOMES 2 YEARS LATER
J. He1,2, J. C. Erhart-Hledik1,2, C. R. Chu1,2; 1Stanford Univ., Stanford, CA, 2VA
Palo Alto Hlth.Care System, Palo Alto, CAO-2
SAFETY AND PRELIMINARY EFFICACY OF PCRX201,
AN INTRA-ARTICULAR GENE THERAPY FOR KNEE
OSTEOARTHRITIS: A PHASE 1, OPEN-LABEL, SINGLE
ASCENDING DOSE STUDY
S. Cohen1, A. Kivitz2, L. Klassen3, M. Nakazawa4, D. Parenti4, M. DiGiorgi4,
R. Winston4; 1Metroplex Clinical Res. Ctr., Dallas, TX, 2Altoona Arthritis and
Osteoporosis Ctr., Duncansville, PA, 3Univ. of Nebraska Med. Ctr., Omaha,
NE, 4Pacira BioSci.s, Inc., Parsippany, NJO-3
COMBINATION OF COMPUTATIONAL METHODS
WITH A DRUG REPURPOSING STRATEGY IDENTIFIES
A COMPOUND TARGETING CHONDROCYTE
HYPERTROPHY
J. Veldman1, M. N. Ferrao Blanco1, N. K. Kops1, K. Sivasubramaniyan1,2,
J. van Rooij1, E. Farrell1, G. J. van Osch1; 1Erasmus MC, Rotterdam,
Netherlands, 2Galapagos Nederland, Leiden, Netherlands